Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics

J. P. Thyssen, D. Thaçi, T. Bieber, M. Gooderham, M. de Bruin-Weller, W. Soong, K. Kabashima, S. Barbarot, P. C. Luna, J. Xu, X. Hu, Y. Liu, E. M. Raymundo, B. M. Calimlim, C. Nduaka, A. Gamelli, E. L. Simpson

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics'. Together they form a unique fingerprint.

Medicine & Life Sciences